Chemical biology tools to study pantetheinases of the vanin family

Biochemical Society Transactions

Volumn 42, Issue 4, 2014, Pages 1052-1055

  Schalkwijk, Joost ^a   Jansen, Patrick ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antibiotic; Coenzyme A (CoA); Malaria; Metabolism; Pantothenic acid

Indexed keywords

ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; ENZYME INHIBITOR; LIPID; PANTETHEINASE; PANTOTHENIC ACID DERIVATIVE; PANTOYLTAURINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN; RR 6; SULFONAMIDE; UNCLASSIFIED DRUG; VANIN 1; AMIDASE; ANTIINFECTIVE AGENT; COENZYME A; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; PANTOTHENIC ACID;

ANIMAL EXPERIMENT; ANTIMALARIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; BACTERIAL VIABILITY; BIOLOGY; BIOSYNTHESIS; CHEMICAL BIOLOGY; COMPETITIVE INHIBITION; CONFERENCE PAPER; DIET RESTRICTION; DRUG BIOAVAILABILITY; DRUG POTENCY; ENERGY METABOLISM; ESCHERICHIA COLI; HIGH THROUGHPUT SCREENING; IC 50; INFLAMMATION; KLEBSIELLA PNEUMONIAE; LIPID BLOOD LEVEL; LIPID LIVER LEVEL; LIPID METABOLISM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUTRITIONAL STATUS; PLASMA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RAT; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS PNEUMONIAE; STRESS; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; METABOLISM;

AMIDOHYDROLASES; ANIMALS; ANTI-BACTERIAL AGENTS; COENZYME A; GPI-LINKED PROTEINS; PANTOTHENIC ACID; PLASMODIUM FALCIPARUM; STAPHYLOCOCCUS AUREUS;

EID: 84905858544     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20140074     Document Type: Conference Paper

References (30)

1. Maras, B., Barra, D., Dupre, S. and Pitari, G. (1999) Is pantetheinase the actual identity of mouse and human vanin-1 proteins?. FEBS Lett. 461, 149-152
2. Kaskow, B.J., Proffitt, J.M., Blangero, J., Moses, E.K. and Abraham, L.J. (2012) Diverse biological activities of the vascular non-inflammatory molecules: the vanin pantetheinases. Biochem. Biophys. Res. Commun. 417, 653-658
3. Martin, F., Malergue, F., Pitari, G., Philippe, J.M., Philips, S., Chabret, C., Granjeaud, S., Mattei, M.G., Mungall, A.J., Naquet, P. and Galland, F. (2001) Vanin genes are clustered (human 6q22-24 and mouse 10A2B1) and encode isoforms of pantetheinase ectoenzymes. Immunogenetics 53, 296-306
4. Pitari, G., Malergue, F., Martin, F., Philippe, J.M., Massucci, M.T., Chabret, C., Maras, B., Dupre, S., Naquet, P. and Galland, F. (2000) Pantetheinase activity of membrane-bound vanin-1: lack of free cysteamine in tissues of vanin-1 deficient mice. FEBS Lett. 483, 149-154
5. Brenner, C. (2002) Catalysis in the nitrilase superfamily. Curr. Opin. Struct. Biol. 12, 775-782
6. Leonardi, R., Zhang, Y.M., Rock, C.O. and Jackowski, S. (2005) Coenzyme A: back in action. Prog. Lipid Res. 44, 125-153
7. Martin, F., Penet, M.F., Malergue, F., Lepidi, H., Dessein, A., Galland, F., de, R.M., Naquet, P. and Gharib, B. (2004) Vanin-1/ mice show decreased NSAID- and Schistosoma-induced intestinal inflammation associated with higher glutathione stores. J. Clin. Invest. 113, 591-597
8. Berruyer, C., Martin, F.M., Castellano, R., Macone, A., Malergue, F., Garrido-Urbani, S., Millet, V., Imbert, J., Dupre, S., Pitari, G. et al. (2004) Vanin-1/ mice exhibit a glutathione-mediated tissue resistance to oxidative stress. Mol. Cell. Biol. 24, 7214-7224
9. Berruyer, C., Pouyet, L., Millet, V., Martin, F.M., LeGoffic, A., Canonici, A., Garcia, S., Bagnis, C., Naquet, P. and Galland, F. (2006) Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor activity. J. Exp. Med. 203, 2817-2827
10. Min-Oo, G., Fortin, A., Pitari, G., Tam, M., Stevenson, M.M. and Gros, P. (2007) Complex genetic control of susceptibility to malaria: positional cloning of the Char9 locus. J. Exp. Med. 204, 511-524
11. Jansen, P.A., Kamsteeg, M., Rodijk-Olthuis, D., van Vlijmen-Willems, I.M., de Jongh, G.J., Bergers, M., Tjabringa, G.S., Zeeuwen, P.L. and Schalkwijk, J. (2009) Expression of the vanin gene family in normal and inflamed human skin: induction by proinflammatory cytokines. J. Invest. Dermatol. 129, 2167-2174
12. Pouyet, L., Roisin-Bouffay, C., Clement, A., Millet, V., Garcia, S., Chasson, L., Issaly, N., Rostan, A., Hofman, P., Naquet, P. and Galland, F. (2010) Epithelial vanin-1 controls inflammation-driven carcinogenesis in the colitis-associated colon cancer model. Inflamm. Bowel Dis. 16, 96-104
13. Dammanahalli, K.J., Stevens, S. and Terkeltaub, R. (2012) Vanin-1 pantetheinase drives smooth muscle cell activation in post-arterial injury neointimal hyperplasia. PLoS ONE 7, e39106
14. Yamazaki, K., Kuromitsu, J. and Tanaka, I. (2002) Microarray analysis of gene expression changes in mouse liver induced by peroxisome proliferator-activated receptor agonists. Biochem. Biophys. Res. Commun. 290, 1114-1122
15. Rakhshandehroo, M., Knoch, B., Muller, M. and Kersten, S. (2010) Peroxisome proliferator-activated receptor target genes. PPAR Res. 2010, 612089
16. Rommelaere, S., Millet, V., Gensollen, T., Bourges, C., Eeckhoute, J., Hennuyer, N., Bauge, E., Chasson, L., Cacciatore, I., Staels, B. et al. (2013) PPAR regulates the production of serum vanin-1 by liver. FEBS Lett. 587, 3742-3748
17. Ruan, B.H., Cole, D.C., Wu, P., Quazi, A., Page, K., Wright, J.F., Huang, N., Stock, J.R., Nocka, K., Aulabaugh, A. et al. (2010) A fluorescent assay suitable for inhibitor screening and vanin tissue quantification. Anal. Biochem. 399, 284-292
18. Jansen, P.A., van Diepen, J.A., Ritzen, B., Zeeuwen, P.L., Cacciatore, I., Cornacchia, C., van Vlijmen-Willems, I.M., de Heuvel, E., Botman, P.N., Blaauw, R.H. et al. (2013) Discovery of small molecule vanin inhibitors: new tools to study metabolism and disease. ACS Chem. Biol. 8, 530-534
19. Suzuki, K., Watanabe, T., Sakurai, S., Ohtake, K., Kinoshita, T., Araki, A., Fujita, T., Takei, H., Takeda, Y., Sato, Y. et al. (1999) A novel glycosylphosphatidyl inositol-anchored protein on human leukocytes: a possible role for regulation of neutrophil adherence and migration. J. Immunol. 162, 4277-4284
20. Huang, J., Takeda, Y., Watanabe, T. and Sendo, F. (2001) A sandwich ELISA for detection of soluble GPI-80, a glycosylphosphatidyl-inositol (GPI)-anchored protein on human leukocytes involved in regulation of neutrophil adherence and migration: its release from activated neutrophils and presence in synovial fluid of rheumatoid arthritis patients. Microbiol. Immunol. 45, 467-471
21. Spry, C., Kirk, K. and Saliba, K.J. (2008) Coenzyme A biosynthesis: an antimicrobial drug target. FEMS Microbiol. Rev. 32, 56-106
22. Clifton, G., Bryant, S.R. and Skinner, C.G. (1970) N'-(substituted) pantothenamides, antimetabolites of pantothenic acid. Arch. Biochem. Biophys. 137, 523-528
23. Ivey, R.A., Zhang, Y.M., Virga, K.G., Hevener, K., Lee, R.E., Rock, C.O., Jackowski, S. and Park, H.W. (2004) The structure of the pantothenate kinase. ADP. pantothenate ternary complex reveals the relationship between the binding sites for substrate, allosteric regulator, and antimetabolites. J. Biol. Chem. 279, 35622-35629
24. Spry, C., Chai, C.L., Kirk, K. and Saliba, K.J. (2005) A class of pantothenic acid analogs inhibits Plasmodium falciparum pantothenate kinase and represses the proliferation of malaria parasites. Antimicrob. Agents Chemother. 49, 4649-4657
25. Thomas, J. and Cronan, J.E. (2010) Antibacterial activity of N-pentylpantothenamide is due to inhibition of coenzyme A synthesis. Antimicrob. Agents Chemother. 54, 1374-1377
26. Jansen, P.A., Hermkens, P.H., Zeeuwen, P.L., Botman, P.N., Blaauw, R.H., Burghout, P., van Galen, P.M., Mouton, J.W., Rutjes, F.P. and Schalkwijk, J. (2013) Combination of pantothenamides with vanin inhibitors as a novel antibiotic strategy against Gram-positive bacteria. Antimicrob. Agents Chemother. 57, 4794-4800
27. Spry, C., Macuamule, C., Lin, Z., Virga, K.G., Lee, R.E., Strauss, E. and Saliba, K.J. (2013) Pantothenamides are potent, on-target inhibitors of Plasmodium falciparum growth when serum pantetheinase is inactivated. PLoS ONE 8, e54974
28. de Villiers, M., Macuamule, C., Spry, C., Hyun, Y., Strauss, E. and Saliba, K. (2013) Structural modification of pantothenamides counteracts degradation by pantetheinase and improves antiplasmodial activity. ACS Med. Chem. Lett. 4, 784-789
29. Jansen, P.A.M., Schalkwijk, J., Rutjes, F.P.J.T., Sauerwein, R. and Hermkens, P.H.H. (2011) Derivatives of pantothenic acid and their use for the treatment of malaria. World Pat. WO2011152721
30. Chen, S., Zhang, W., Tang, C., Tang, X., Liu, L. and Liu, C. (2014) Vanin-1 is a key activator for hepatic gluconeogenesis. Diabetes 63, 2073-2085